<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05002166</url>
  </required_header>
  <id_info>
    <org_study_id>Infilamatory bowel disease</org_study_id>
    <nct_id>NCT05002166</nct_id>
  </id_info>
  <brief_title>Clinical Characteristics and Risk Factors of Children Suffering From Inflammatory Bowel Diseases At Assiut University Children Hospital</brief_title>
  <official_title>Clinical Characteristics and Risk Factors of Children Suffering From Inflammatory Bowel Diseases At Assiut University Children Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical Characteristics and Risk factors of Children Suffering from Inflammatory Bowel&#xD;
      Diseases At Assiut University Children Hospital&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients admitted with inflammatory bowel disease will be subjected to:&#xD;
&#xD;
        1. History: including name, age ,sex ,family history, consanguinity, history of rectal&#xD;
           bleeding, mucus or blood in the stool, diarrhea, abdominal pain ,vomiting ,nausea and&#xD;
           loss of appetite.&#xD;
&#xD;
        2. Examination: including general examination, chest, cardiac, abdominal and neurological&#xD;
           examination&#xD;
&#xD;
        3. Investigation:including labortatory such as fecal calprotectin ,CRP,CBC,ESR. Endoscopic&#xD;
           examination of the gastrointestinal tract Histological examination of the biopsies&#xD;
           retrieved during gastrointestinal endoscope.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 5, 2021</start_date>
  <completion_date type="Anticipated">July 20, 2027</completion_date>
  <primary_completion_date type="Anticipated">July 20, 2027</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical characteristics and risk factors for IBD</measure>
    <time_frame>6 months</time_frame>
    <description>To study the natural history, patterns, and clinical characteristics (as history of real bleeding, mucus or blood in the stool, diarrhea, abdominal pain ,vomiting)and risk factors of inflammatory bowel diseases (IBD) at Assiut University Children Hospital</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Inflammatory Bowel Disease</condition>
  <arm_group>
    <arm_group_label>Children aged less than 18 years with a confirmed diagnosis of IBD.</arm_group_label>
    <description>All patients admitted with inflammatory bowel disease will be subjected to:&#xD;
History: including name, age ,sex ,family history, consanguinity, history of rectal bleeding, mucus or blood in the stool, diarrhea, abdominal pain ,vomiting ,nausea and loss of appetite.&#xD;
Examination: including general examination, chest, cardiac, abdominal and neurological examination&#xD;
Investigation:including labortatory such as fecal calprotectin ,CRP,CBC,ESR. Endoscopic examination of the gastrointestinal tract Histological examination of the biopsies retrieved during gastrointestinal endoscope.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>labortatory such as fecal calprotectin ,CRP,CBC,ESR. Endoscopic examination of the gastrointestinal tract Histological examination of the biopsies retrieved during gastrointestinal endoscope.</intervention_name>
    <description>labortatory such as fecal calprotectin ,CRP,CBC,ESR. Endoscopic examination of the gastrointestinal tract Histological examination of the biopsies retrieved during gastrointestinal endoscope.</description>
    <arm_group_label>Children aged less than 18 years with a confirmed diagnosis of IBD.</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients admitted with inflammatory bowel disease&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Children aged less than 18 years with a confirmed diagnosis of IBD.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Children with colitis other than IBD or children with systemic diseases affecting GIT.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shereen Mansour, Lecturer</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christine Zaghloul, Resident</last_name>
    <phone>01289132810</phone>
    <email>christinezaghloul@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maher Mokhtar, Professor</last_name>
    <phone>01062052802</phone>
    <email>maher.mokhtar@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Christine zaghloul noos</name>
      <address>
        <city>Assiut</city>
        <zip>23123</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Zaghloul, Resident</last_name>
      <phone>01289132810</phone>
      <email>christinezaghloul@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Shereen Mansour, Lecturer</last_name>
      <phone>01003162310</phone>
      <email>Shyreen.ahmed@med.au.edu.eg</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 20, 2021</study_first_submitted>
  <study_first_submitted_qc>August 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 12, 2021</study_first_posted>
  <last_update_submitted>August 4, 2021</last_update_submitted>
  <last_update_submitted_qc>August 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Christine Zaghloul Noos</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

